Xenidate XL
Methylphenidate hydrochloride (prolonged-release tablet)
Overview
Medication class
Xenidate XL (Viatris) is a prolonged-release methylphenidate tablet confirmed bioequivalent to Concerta XL by SPS August 2025. It delivers approximately 22% of the dose as an initial release in the first 1–2 hours, with the remainder releasing gradually to maintain 12 hours of therapeutic coverage. Xenidate XL is not pH-dependent: compatible with PPIs and antacids, and requires no food. MHRA guidance (September 2022): Methylphenidate MR products must be prescribed and dispensed by brand name. Xenidate XL is not interchangeable with other brands without clinical review.
When it's prescribed
Prescribed for ADHD in children aged 6 and over and adults, per NICE NG87. Must be prescribed and dispensed by brand name (MHRA guidance, September 2022).
Typical duration
Up to 12 hours
Available strengths
18 mg, 27 mg, 36 mg, 54 mg. Maximum: 54 mg/day (children); up to 72 mg/day (adults) per SmPC.
Key advantages
- 12-hour duration: full working-day coverage from a single morning tablet
- Not pH-dependent: compatible with PPIs and antacids
- No food requirement
- Bioequivalent to Concerta XL: the reference product
- Part of the largest UK bioequivalence group: supply options available within group
- Adult SmPC confirms up to 72 mg/day: useful where higher doses are needed
Key cautions
- Tablet must be swallowed whole: cannot be crushed, cut, or opened
- Lower first peak than capsule brands: effect builds gradually through the morning
- You may see a tablet shell in stools; this is normal and means the medication has worked
How it works
Methylphenidate blocks the brain's recycling transporters for dopamine and noradrenaline: keeping them available longer in the synapse. This isn't the same as amphetamines: methylphenidate slows the drain rather than turning up the tap.
Xenidate XL is a prolonged-release tablet bioequivalent to Concerta XL (the reference product). It delivers an initial portion of the dose in the first 1–2 hours, then releases the remainder gradually: maintaining therapeutic plasma levels for up to 12 hours.
The tablet must remain intact for the release mechanism to work correctly. Crushing or breaking it releases the full dose at once.
Xenidate XL is not pH-dependent: compatible with acid-suppression medications.
How to take it
When to take it
Once in the morning. Up to 12 hours' duration: take before 9am to avoid it being active at bedtime.
With or without food
Either is fine: Xenidate XL does not require food.
Swallow whole
Take with a full glass of water. Do not crush, break, chew, or cut the tablet: the prolonged-release mechanism only works as an intact tablet.
Tablet shell in stools
You may notice a tablet shell in your stools. This is normal; it means the medication has released correctly and the shell has passed through harmlessly.
Missed dose
If still morning, take as soon as you remember. If mid-afternoon, skip it and resume tomorrow. Never double up.
Alcohol
Avoid entirely. Alcohol can cause dose-dumping from the prolonged-release mechanism and reacts with methylphenidate to form ethylphenidate. Both carry risk.
Before surgery
Tell your surgical team you take methylphenidate. Check with your prescriber about whether to take it on the day of surgery.
What to expect: week by week
Adjustment
Appetite dips (especially afternoons); mild headache (usually dehydration: drink more water); possibly feeling more alert or on edge. Most settle by week 2.
Settling in
Most early side effects reduce. Coverage builds gradually: some people notice the effect strengthens through the morning rather than being immediate. This is how prolonged-release tablets work.
Optimising
Titration in 18 mg increments. The goal is the lowest dose that manages symptoms well for long enough, with the fewest side effects.
Maintenance
Reviews every 6 months. BP, HR, and weight checked at each visit.
Side effects & what helps
All expanded by default: tap a category to collapse it. Most of these ease in the first 1–2 weeks.
Reduced appetite; weight loss (long-term)
Very common (more than 1 in 10)What helps
Appetite usually returns in the evening. Monitored at every review.
Difficulty sleeping if taken late
Very commonWhat helps
Take before 9am. Still disrupted at 4 weeks: discuss with your prescriber.
Increased HR and BP; palpitations
CommonWhat helps
Monitored at every review. Contact prescriber if resting HR consistently above 100 bpm.
Anxiety, irritability, low mood
CommonWhat helps
Tell your prescriber if persistent.
Suicidal thoughts
UncommonWhat helps
Contact prescriber or crisis support immediately.
Psychosis symptoms; mania
Uncommon/RareWhat helps
Stop and seek urgent review.
Headache
Very commonWhat helps
Usually settles by week 2. Drink more water.
Dizziness, tremor
CommonWhat helps
Don't drive while dizzy.
Tics
RareWhat helps
Contact your prescriber.
Nausea, dry mouth, sweating
CommonWhat helps
Mention at your next review if troublesome.
Priapism (painful erection more than 2 hours)
Rare: medical emergencyWhat helps
Attend A&E immediately.
When to seek help
Expected: mention at next review
Common in the first few weeks: no action usually needed
- Reduced appetite (stable)
- Mild headache weeks 1–2
- Dry mouth
- Mild sleep difficulty
- Mild irritability improving
Contact your prescriber within a few days
Not urgent: but worth discussing at your next review
- Resting HR consistently >100 bpm
- BP persistently raised
- Headaches beyond 2 weeks
- Mood changes not settling at 4 weeks
- Sleep severely disrupted beyond 4 weeks
- Significant weight loss
- Tics appearing
- Blurred vision; Raynaud's symptoms
Contact prescriber or 111 today
Do not wait for a routine appointment
- Resting HR >120 bpm; BP significantly raised; fainting
- Suicidal thoughts
- Hallucinations or psychosis
- Priapism
- Severe allergic reaction
- New mania
What you can safely try while waiting for a review
Frequently asked questions
How is Xenidate XL different from Concerta XL?
They have the same clinical profile: Xenidate XL is confirmed bioequivalent to Concerta XL by the NHS SPS. They contain the same active ingredient at the same dose and have the same 12-hour duration. The manufacturers differ (Xenidate XL is made by Viatris; Concerta XL by Janssen-Cilag). Your prescriber or pharmacist may have chosen Xenidate XL for availability or formulary reasons.
My pharmacy gave me a different brand. Is that okay?
Not without speaking to your prescriber first. Even though Xenidate XL is part of the tablet bioequivalence group, brands should not be swapped without guidance. Ask your pharmacy to order Xenidate XL specifically.
Can I take it with omeprazole?
Yes: Xenidate XL is not pH-dependent, so PPIs and antacids do not affect it. (This is different from Medikinet XL, where they are contraindicated.)
Can I drink alcohol?
Avoid it entirely: dose-dumping risk and ethylphenidate formation.
There's a shell in my stools. Has the tablet passed through without working?
No; this is normal for some prolonged-release tablets. The shell is inert and passes through after the medication has already been absorbed. It means the tablet worked correctly.
I'm pregnant or breastfeeding: what do I need to know?
Pregnancy: Current evidence (BUMPS/UKTIS, January 2023): speak to your prescriber before changing anything. Do not stop without advice. Breastfeeding: Methylphenidate is considered the stimulant of choice during breastfeeding (BfN, April 2025). Milk levels are very low. You do not need to stop breastfeeding. Use lowest effective dose, time after feeds where possible, monitor baby.
Ask your prescriber
Questions worth raising at your next review. You don't need to cover all of them: pick the ones that feel most relevant.
- Why Xenidate XL for me specifically?
- What dose are we starting at, and what is the maximum?
- What if my pharmacy can't get Xenidate XL: can they give me a different brand?
- What side effects should I call you about?
- I take [list medications]: are any of these a concern?
- If Xenidate XL doesn't work well enough, what would we try next?
For GPs & clinicians
Xenidate XL (Viatris): prolonged-release tablet; ~22:78 IR:MR; bioequivalent to Concerta XL per SPS August 2025. Ascending 12h profile. Not pH-dependent. No food requirement. Swallow whole only.
Affenid XL, Atenza XL, Concerta XL, Delmosart, Matoride XL, Xaggitin XL, Xenidate XL: interchangeable within group at same dose and quantity if supply disruption. Switches to/from capsule group (Ritalin XL, Medikinet XL, Meflynate XL etc.) or Equasym XL require specialist review.
SmPC confirms up to 72 mg/day for adults. Used under specialist direction per NICE NG87. BP and HR at baseline, dose changes, minimum every 6 months. Weight at each review.
MAOIs (contraindicated, 14-day washout); alcohol (ethylphenidate formation, dose-dumping); antihypertensives (reduced efficacy); coumarin anticoagulants (monitor INR).
Pregnancy (BUMPS/UKTIS January 2023): Individual risk-benefit; do not advise abrupt discontinuation. Breastfeeding (BfN April 2025): Stimulant of choice; very low RID; no need to stop breastfeeding.
This guide is written for educational purposes and does not constitute medical advice. Always follow the guidance of your prescriber or pharmacist. If you have concerns about your medication, contact your clinical team.